Peptidream Inc. 4587

Completion of patient dosing in the registrational Phase 2 clinical trial for 64Cu-PSMA-I&T - a PET radiopharmaceutical targeting prostate-specific membrane antigen (PSMA) expressed on prostate cancer cellsData analysis is now underway to support future regulatory submission in Japan BOSTON, June 11, 2026 (GLOBE NEWSWIRE) -- Curium Group announced today that together with PeptiDream Inc. and PDRadiopharma Inc., patient dosing has been completed in the registrational Phase 2 clinical trial for 64

PeptiDream’s latest analyst update centers on a sharp reset in the 12 month price target, cut from ¥2,700 to ¥1,600. Bulls argue this lower target now better matches the current pace of out licensing and turns the recent downgrade to Neutral into more of a sentiment reset. Bears, however, see it as a sign of reduced conviction around monetizing the pipeline. As you read on, you will see what this shift could mean for expectations and how to track the story as new licensing milestones...

As the Asian markets navigate a complex landscape of regulatory shifts and geopolitical developments, investors are keenly observing opportunities that arise from these fluctuations. In this context, identifying undervalued stocks becomes crucial, as they can offer potential investment opportunities amidst broader market uncertainties.

As the Asian markets navigate a landscape marked by regulatory shifts in China and political developments in Japan, investors are increasingly focused on identifying stocks that may be trading below their intrinsic value. In this context, a good stock is typically characterized by strong fundamentals and resilience to market volatility, offering potential opportunities for those seeking value investments amid the current economic climate.

As we enter 2026, Asian markets are capturing attention with their resilience amidst global economic shifts, including geopolitical tensions and evolving trade dynamics. Investors are increasingly on the lookout for undervalued stocks that may offer potential opportunities in this environment, where identifying value requires a keen eye on fundamentals and market trends.

As Asian markets experience a mix of geopolitical tensions and economic shifts, investors are increasingly on the lookout for opportunities that may be priced below their intrinsic value. In this context, identifying stocks with strong fundamentals and potential resilience amidst broader market fluctuations can be crucial for those considering investments in the region.